Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
4 Sound blocking Earphones for Prevalent Sound and Solace - 2Archaeologists uncover details about the Hjortspring boat's origins
- 3Surging measles cases are 'fire alarm' warning that other diseases could be next
- 4The most effective method to Go with Informed Choices on Vehicle Leases
- 5Which Switch Game Do You Suggest? Share Your Decision
- Wedding trip Objections in Europe
- SpaceX launches Starlink satellites from California on 160th Falcon 9 flight of the year (video)
- UN chief calls on Yemen's Houthi rebels to free all UN detainees
- China's Normal Ponders: A Visual Excursion
- How to watch the ‘Wicked: One Wonderful Night’ special — now streaming
- Antivirus Programming for Exhaustive Security
- What is Fusarium graminearum, the fungus a Chinese scientist pleaded guilty to smuggling into the US?
- The Excursion to Monetary Proficiency: Individual budget Triumphs
- Toddler given just 3 years to live after strange symptoms makes full recovery
